Literature DB >> 1867194

The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.

D M Hallman1, E Boerwinkle, N Saha, C Sandholzer, H J Menzel, A Csázár, G Utermann.   

Abstract

Application of uniform methods for measuring the apolipoprotein (apo) E polymorphism and plasma cholesterol levels in nine populations (Tyrolean, Sudanese, Indian, Chinese, Japanese, Hungarian, Icelandic, Finnish, and Malay) revealed significant heterogeneity among them in apo E type frequencies and mean cholesterol levels. The major apo E types in all populations were E3/2 (frequency range from 7.0% in Indians to 16.9% in Malays), E3/3 (frequency range from 39.8% in Sudanese to 72.1% in Japanese), and E3/4 (frequency range from 11.3% in Japanese to 35.9% in Sudanese). Mean cholesterol levels ranged from 144.2 mg/dl in the Sudanese to 228.5 mg/dl in the Icelandics. Two-way analysis of variance of the effect of population and apo E type on cholesterol levels showed no significantly interaction effect, indicating that the effects of apo E type on cholesterol levels do not differ significantly among the populations. The overall average excess for the epsilon 2 allele was -14.12 mg/dl (range -31.63 to -8.82 mg/dl); for the epsilon 3 allele, 0.04 mg/dl (range -1.87 to 1.58 mg/dl; and for the epsilon 4 allele, 8.14 mg/dl (range -1.71 to 13.31 mg/dl). Despite the apparent heterogeneity in these values, especially for the epsilon 4 allele, comparison of the average excesses by a method of repeated sampling with random permutations revealed no significant difference in effects among populations. These data indicate that a given apo E allele acts in a relatively uniform manner in different populations despite differences in genetic background and environmental factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867194      PMCID: PMC1683282     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Charts of the power function for analysis of variance tests, derived from the non-central F-distribution.

Authors:  E S PEARSON; H O HARTLEY
Journal:  Biometrika       Date:  1951-06       Impact factor: 2.445

2.  Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDL or LDL, or with apoE isoform phenotype.

Authors:  R H Palmer; A V Nichols; R B Dell; R Ramakrishnan; F T Lindgren; E L Gong; C B Blum; D S Goodman
Journal:  J Lipid Res       Date:  1986-06       Impact factor: 5.922

3.  Coronary atherosclerosis in Nigeria.

Authors:  A O Williams
Journal:  Br Heart J       Date:  1971-01

4.  The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals.

Authors:  E Boerwinkle; S Visvikis; D Welsh; J Steinmetz; S M Hanash; C F Sing
Journal:  Am J Med Genet       Date:  1987-07

Review 5.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

6.  The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.

Authors:  U Beisiegel; W Weber; G Ihrke; J Herz; K K Stanley
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

7.  Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks.

Authors:  B Sepehrnia; M I Kamboh; L L Adams-Campbell; C H Bunker; M Nwankwo; P P Majumder; R E Ferrell
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

8.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

Authors:  R C Kowal; J Herz; J L Goldstein; V Esser; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change.

Authors:  C F Xu; E Boerwinkle; M J Tikkanen; J K Huttunen; S E Humphries; P J Talmud
Journal:  Genet Epidemiol       Date:  1990       Impact factor: 2.135

10.  Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects.

Authors:  M D Shriver; E Boerwinkle; D Hewett-Emmett; C L Hanis
Journal:  Diabetes       Date:  1991-03       Impact factor: 9.461

View more
  92 in total

1.  Modeling the effects of genetic factors on late-onset diseases in cohort studies.

Authors:  Mark E Glickman; David R Gagnon
Journal:  Lifetime Data Anal       Date:  2002-09       Impact factor: 1.588

2.  Interaction of apolipoprotein E genotype and dietary cholesterol in determining plasma cholesterol levels.

Authors:  R E Ferrell; M I Kamboh
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

3.  Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism.

Authors:  Jari H Stengård; Andrew G Clark; Kenneth M Weiss; Sharon Kardia; Deborah A Nickerson; Veikko Salomaa; Christian Ehnholm; Eric Boerwinkle; Charles F Sing
Journal:  Am J Hum Genet       Date:  2002-08-05       Impact factor: 11.025

4.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

5.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

Authors:  G Malek; L V Johnson; B E Mace; P Saloupis; D E Schmechel; D W Rickman; C A Toth; P M Sullivan; C Bowes Rickman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

Review 6.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study.

Authors:  M J Mosher; L A Lange; B V Howard; E T Lee; L G Best; R R Fabsitz; J W Maccluer; K E North
Journal:  Genes Nutr       Date:  2008-03-29       Impact factor: 5.523

8.  Estrogen receptor beta polymorphisms and cognitive performance in women: associations and modifications by genetic and environmental influences.

Authors:  Karin Fehsel; Tamara Schikowski; Michaela Jänner; Anke Hüls; Mohammed Voussoughi; Thomas Schulte; Andrea Vierkötter; Tom Teichert; Christian Herder; Dorothea Sugiri; Ursula Krämer; Christian Luckhaus
Journal:  J Neural Transm (Vienna)       Date:  2016-09-14       Impact factor: 3.575

9.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

10.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.